Company / Net Income
Solid Biosciences Inc. Net Income History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$88.3M
FY2022
5-year range
-$117.2M / -$21.5M
FY2018-FY2022
Trend
+24.7%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income returned to growth in FY2022 after 3 years of decline, reaching -$88M.
Based on SEC 10-K filings.
-$88M in FY2022.
Declined from -$75M to -$88M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, net income increased 24.7% year-over-year.
- Peak net income was recorded in FY2018.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$88.3M | +24.7% |
| FY2021 | -$117.2M | -56.7% |
| FY2020 | -$74.8M | -43.5% |
| FY2019 | -$52.1M | -142.0% |
| FY2018 | -$21.5M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026